Vishnu Chemicals Limited
Momentum (74/100) does the heavy lifting; valuation (11/100) is the drag.
ExpensiveOvervaluedStocksWizard rates Vishnu Chemicals Limited a Hold, scoring 45/100 on our blended model. At ₹613.25 it trades above our blended DCF and relative-multiples fair value of ₹385.75, about 37% downside to that estimate — we read it as overvalued by 37%. On 29.9x trailing earnings it sits pricier than the Basic Materials median of about 22.2x. The price is about 4% below its 52-week high of ₹640.45 and 35% above the low of ₹452.7. Financial health scores 73/100, in the safe band on the Altman Z-score, with a Piotroski F-score of 3/9. The average analyst target of ₹650 implies about 6% upside across 1 analysts. It clears 7 of 13 investability checks, with durability 53, valuation 21 and momentum 74 on our 0–100 scales.
Analysis by Ankit Sharma · StocksWizard's own estimates from end-of-day public data — see how we calculate them. For information only, not investment advice.
With a 20% margin of safety, our buy-below price is ₹308.6.
Analyst views
1-year price
EOD · 2026-07-3152-week range
-4.25% from the 52-week high.
Price above both moving averages reads as an intact uptrend; below both, the trend is against you.
Verdict pillars
Hold45Piotroski F-score 3/9 — quality of earnings & balance sheet.
Our scores
Durability rewards strong, low-debt, profitable businesses; Valuation rewards stocks cheap vs their sector; Momentum rewards strong price trends.
Investability checklist
- Fail: ROE above 15%: 14.2%
- Pass: Low debt (D/E < 0.5): 0.49x
- Fail: Positive free cash flow
- Pass: Revenue growth > 10%: 15%
- Pass: Earnings growing: 12%
- Fail: Net margin ≥ 10%: 8.8%
- Pass: Current ratio > 1.5: 1.60
- Fail: Below our fair value
- Fail: Margin of safety ≥ 20%
- Pass: Above 200-day average
- Pass: Above 50-day average
- No data: Positive 1-year return
- Pass: Altman Z in safe zone: Z 3.91
- Fail: Piotroski ≥ 7: 3/9
Quarterly results
Annual financials
Shareholding
- Promoter70.1%
- Institutions8.0%
- Public & other22.0%
Promoter holding via insider stake; institutional via reported holdings.
Key fundamentals
Bull case vs bear case
Bull case
Strengths
- Financially solid — Altman Z 3.91.
Opportunities
- Revenue growing (15% YoY).
Bear case
Weaknesses
- Weak Piotroski score (3/9).
Threats
- Rich valuation versus sector peers.
- Trades ~37% above our estimated fair value.
About Vishnu Chemicals Limited
Vishnu Chemicals Limited manufactures and sells chromium chemicals in India, including sodium dichromate, basic chromium sulphate, chromic acid, chrome oxide green, white sodium sulphate, and potassium dichromate. The company also produces barium carbonate, precipitated barium sulphate, and sodium sulphide. Its products serve the pharmaceutical, consumer goods, glass, pigment and dye, leather, automotive, and wood preservative industries.
Vishnu Chemicals Limited — frequently asked questions
Is Vishnu Chemicals Limited a buy, hold or sell?
StocksWizard currently rates Vishnu Chemicals Limited (VISHNU) a Hold, based on a blended score of 45/100 across valuation, quality, momentum and price trend. This is our own model-based view, not investment advice.
What is Vishnu Chemicals Limited's fair value?
Our blended DCF and relative-valuation model estimates Vishnu Chemicals Limited's fair value at about ₹385.75, versus a current price of ₹613.25 — roughly 37% downside. On that basis the stock looks overvalued by 37%.
Is Vishnu Chemicals Limited financially healthy?
Vishnu Chemicals Limited scores 73/100 on our financial-health model, placing it in the safe band on the Altman Z-score, with a Piotroski F-score of 3/9.
How has Vishnu Chemicals Limited's share price performed?
Vishnu Chemicals Limited is up 1% over three months, and last traded at ₹613.25. Past performance doesn't predict future returns.
More in Basic Materials
View allOur verdict, fair value, financial-health and checklist are StocksWizard's own estimates, computed from public end-of-day data using standard models (DCF, relative valuation, Altman Z, Piotroski). For information only — not investment advice or a recommendation. Verify independently before investing.